Somerville, E. N., James, A., Beetz, C., Schwieger, R., Barrel, G., Kandaswamy, K. K., Iurascu, M. I., Bauer, P., Ta, M., Iwaki, H., Senkevich, K., Yu, E., Alcalay, R. N., & Gan‐Or, Z. (2025). Plasma Glucosylceramide Levels Are Regulated by ATP10D and Are Not Involved in Parkinson’s Disease Pathogenesis. Annals of Neurology. Portico. https://doi.org/10.1002/ana.27219

Jones-Tabah, J., He, K., Karpilovsky, N., Senkevich, K., Deyab, G., Pietrantonio, I., Goiran, T., Cousineau, Y., Nikanorova, D., Goldsmith, T., del Cid Pellitero, E., Chen, C. X.-Q., Luo, W., You, Z., Abdian, N., Ahmad, J., Ruskey, J. A., Asayesh, F., Spiegelman, D., … Fon, E. A. (2024). The Parkinson’s disease risk gene cathepsin B promotes fibrillar alpha-synuclein clearance, lysosomal function and glucocerebrosidase activity in dopaminergic neurons. Molecular Neurodegeneration, 19(1). https://doi.org/10.1186/s13024-024-00779-9

SahBandar, I. N., Maegawa, G. H. B., Brandman, D., Rand, J. H., Lim, H. I., & Geyer, J. T. (2024). A diagnosis of non‐neuronopathic and late‐onset acid sphingomyelinase deficiency (Niemann‐Pick disease A/B) following bone marrow biopsy showing foamy histiocytosis. EJHaem, 5(5), 1078–1079. Portico. https://doi.org/10.1002/jha2.1003

Shiner, T., Kavé, G., Mirelman, A., Regev, K., Piura, Y., Goldstein, O., Gana Weisz, M., Bar‐Shira, A., Gurevich, T., Orr‐Urtreger, A., Alcalay, R. N., Giladi, N., & Bregman, N. (2024). Effect of GBA1 Mutations and APOE Polymorphisms on Survival and Progression Among Ashkenazi Jews with Dementia with Lewy Bodies. Movement Disorders. Portico. https://doi.org/10.1002/mds.30003

LoPiccolo, M. K., Wang, Z., Eshed, G. M., Fierro, L., Stauffer, C., Wang, K., Zhang, J., Tatsuoka, C., Balwani, M., Zou, W., & Alcalay, R. N. (2024). Skin α‐Synuclein Seeding Activity in Patients with Type 1 Gaucher Disease. Movement Disorders. Portico. https://doi.org/10.1002/mds.29935

Chang, S., Zhan, X., Liu, Y., Song, H., Gong, Z., Han, L., Maegawa, G. H. B., Gu, X., & Zhang, H. (2024). Newborn Screening for 6 Lysosomal Storage Disorders in China. JAMA Network Open, 7(5), e2410754. https://doi.org/10.1001/jamanetworkopen.2024.10754

Sparks, J., Michelassi, F., Thompson, J. L. P., Buchsbaum, R., Pires, N., DeRosa, J. T., Engelstad, K., DiMauro, S., Akman, H. O., & Hirano, M. (2024). A United States-based patient-reported adult polyglucosan body disease registry: initial results. Therapeutic Advances in Rare Disease, 5. https://doi.org/10.1177/26330040241227452

Chen, J., Cazenave-Gassiot, A., Xu, Y., Piroli, P., Hwang, R., DeFreitas, L., Chan, R. B., Di Paolo, G., Nandakumar, R., Wenk, M. R., & Marquer, C. (2023). Lysosomal phospholipase A2 contributes to the biosynthesis of the atypical late endosome lipid bis(monoacylglycero)phosphate. Communications Biology, 6(1). https://doi.org/10.1038/s42003-023-04573-z

Westerterp, M., Li, F., & Zhang, H. (2023). Dissecting cell type–specific impact in lysosomal acid lipase deficiency–associated disorders. Journal of Lipid Research, 64(12), 100474. https://doi.org/10.1016/j.jlr.2023.100474

Rekova, P., Dostalova, G., Rob, D., Vaneckova, M., Pavlicova, M., Linhart, A., & Kemlink, D. (2023). Cerebrovascular Phenotype in Fabry Disease Patients Assessed by Ultrasound. Journal of Ultrasound in Medicine, 42(10), 2315–2330. Portico. https://doi.org/10.1002/jum.16254

Qi, R., Sammler, E., Gonzalez-Hunt, C. P., Barraza, I., Pena, N., Rouanet, J. P., Naaldijk, Y., Goodson, S., Fuzzati, M., Blandini, F., Erickson, K. I., Weinstein, A. M., Lutz, M. W., Kwok, J. B., Halliday, G. M., Dzamko, N., Padmanabhan, S., Alcalay, R. N., Waters, C., … Sanders, L. H. (2023). A blood-based marker of mitochondrial DNA damage in Parkinson’s disease. Science Translational Medicine, 15(711). https://doi.org/10.1126/scitranslmed.abo1557

Zhan, X., Zhang, H., Maegawa, G. H. B., Wang, Y., Gao, X., Wang, D., & Li, J. (2023). Use of Ambroxol as Therapy for Gaucher Disease. JAMA Network Open, 6(6), e2319364. https://doi.org/10.1001/jamanetworkopen.2023.19364

Chen, J., Soni, R. K., Xu, Y., Simoes, S., Liang, F.-X., DeFreitas, L., Hwang, R., Montesinos, J., Lee, J. H., Area-Gomez, E., Nandakumar, R., Vardarajan, B., & Marquer, C. (2023). Juvenile CLN3 disease is a lysosomal cholesterol storage disorder: similarities with Niemann-Pick type C disease. EBioMedicine, 92, 104628. https://doi.org/10.1016/j.ebiom.2023.104628

Gehin, C., Lone, M. A., Lee, W., Capolupo, L., Ho, S., Adeyemi, A. M., Gerkes, E. H., Stegmann, A. P. A., López-Martín, E., Bermejo-Sánchez, E., Martínez-Delgado, B., Zweier, C., Kraus, C., Popp, B., Strehlow, V., Gräfe, D., Knerr, I., Jones, E. R., Zamuner, S., … Gennarino, V. A. (2023). CERT1 mutations perturb human development by disrupting sphingolipid homeostasis. Journal of Clinical Investigation, 133(10). https://doi.org/10.1172/jci165019

Planas-Serra, L., Launay, N., Goicoechea, L., Heron, B., Jou, C., Juliá-Palacios, N., Ruiz, M., Fourcade, S., Casasnovas, C., De La Torre, C., Gelot, A., Marsal, M., Loza-Alvarez, P., García-Cazorla, À., Fatemi, A., Ferrer, I., Portero-Otin, M., Area-Gómez, E., & Pujol, A. (2023). Sphingolipid desaturase DEGS1 is essential for mitochondria-associated membrane integrity. Journal of Clinical Investigation, 133(10). https://doi.org/10.1172/jci162957

Blauwendraat, C., Tayebi, N., Woo, E. G., Lopez, G., Fierro, L., Toffoli, M., Limbachiya, N., Hughes, D., Pitz, V., Patel, D., Vitale, D., Koretsky, M. J., Hernandez, D., Real, R., Alcalay, R. N., Nalls, M. A., Morris, H. R., Schapira, A. H. V., Balwani, M., & Sidransky, E. (2023). Polygenic Parkinson’s Disease Genetic Risk Score as Risk Modifier of Parkinsonism in Gaucher Disease. Movement Disorders, 38(5), 899–903. Portico. https://doi.org/10.1002/mds.29342

Kolesnikova, M., Lima de Carvalho, J. R., Oh, J. K., Soucy, M., Demirkol, A., Kim, A. H., Tsang, S. H., & Breazzano, M. P. (2023). Phenotypic Variability of Retinal Disease Among a Cohort of Patients With Variants in the CLN Genes. Investigative Opthalmology & Visual Science, 64(3), 23. https://doi.org/10.1167/iovs.64.3.23

Kedariti, M., Frattini, E., Baden, P., Cogo, S., Civiero, L., Ziviani, E., Zilio, G., Bertoli, F., Aureli, M., Kaganovich, A., Cookson, M. R., Stefanis, L., Surface, M., Deleidi, M., Di Fonzo, A., Alcalay, R. N., Rideout, H., Greggio, E., & Plotegher, N. (2022). LRRK2 kinase activity regulates GCase level and enzymatic activity differently depending on cell type in Parkinson’s disease. Npj Parkinson’s Disease, 8(1). https://doi.org/10.1038/s41531-022-00354-3

Azab, B., Rabab’h, O., Aburizeg, D., Mohammad, H., Dardas, Z., Mustafa, L., Khasawneh, R. A., Awad, H., Hatmal, M. M., & Altamimi, E. (2022). Potential Composite Digenic Contribution of NPC1 and NOD2 Leading to Atypical Lethal Niemann-Pick Type C with Initial Crohn’s Disease-like Presentation: Genotype-Phenotype Correlation Study. Genes, 13(6), 973. https://doi.org/10.3390/genes13060973

Liaqat, K., Hussain, S., Acharya, A., Nasir, A., Bharadwaj, T., Ansar, M., Basit, S., Schrauwen, I., Ahmad, W., & Leal, S. M. (2022). Phenotype Expansion for Atypical Gaucher Disease Due to Homozygous Missense PSAP Variant in a Large Consanguineous Pakistani Family. Genes, 13(4), 662. https://doi.org/10.3390/genes13040662

Dong, C., Honrao, C., Rodrigues, L. O., Wolf, J., Sheehan, K. B., Surface, M., Alcalay, R. N., & O’Day, E. M. (2022). Plasma Metabolite Signature Classifies Male LRRK2 Parkinson’s Disease Patients. Metabolites, 12(2), 149. https://doi.org/10.3390/metabo12020149

Peterschmitt, M. J., Saiki, H., Hatano, T., Gasser, T., Isaacson, S. H., Gaemers, S. J. M., Minini, P., Saubadu, S., Sharma, J., Walbillic, S., Alcalay, R. N., Cutter, G., Hattori, N., Höglinger, G. U., Marek, K., Schapira, A. H. V., Scherzer, C. R., Simuni, T., … Fischer, T. Z. (2022). Safety, Pharmacokinetics, and Pharmacodynamics of Oral Venglustat in Patients with Parkinson’s Disease and a GBA Mutation: Results from Part 1 of the Randomized, Double-Blinded, Placebo-Controlled MOVES-PD Trial. Journal of Parkinson’s Disease, 12(2), 557–570. https://doi.org/10.3233/jpd-212714